Malaysia “Tracvirus SafeTravelPass” System Integrator Contract awarded to OTTIGO by Nexgram units Tri-G and VaccinesLab to collect payment for government agencies for inbound travellers Covid-19 Screening Test, Quarantine, and Vaccine tracing. [11 Nov 2020] Press Release


Kuala Lumpur, Malaysia (Nov 11 2020): Nexgram Holdings Berhad’s (“Nexgram”) sub- subsidiaries, Tri-G Technologies Sdn Bhd (“TRI-G”) and Vaccines Lab Sdn Bhd (“VaccinesLab”) awarded “Tracvirus SafeTravelPass” Panel Government System Integrator Contract (“PGSIC”) to OTTIGO Sdn Bhd which is developed to collect payment on behalf of Ministry of Health (“MOH”) for inbound travellers who conduct Covid-19 Screening Test, Quarantine, and coming vaccine tracing on borders and airports in Malaysia. The application came with ready vaccine tracing system, trackable and accessible worldwide.

The contract is awarded to e-government and online payment solution provider OTTIGO to upgrade and maintain existing online payment system for Tracvirus Covid-19 screening and quarantine, as well as further integration of Tracvirus MOH accredited panel laboratories (“labs”), and MOH approved hotels and quarantine centers nationwide.

On 4 November 2020, Nexgram inked letter of acceptance by Majlis Keselamatan Negara (“MKN”) to Tracvirus electronic health check system for inbound travellers for MOH.

Tracvirus Open Platform was launched in Malaysia and Indonesia in July 2020, followed by the launch of “Tracvirus SafeTravelPass”, an Electronic Certificate (“E-Cert”) for inbound travellers, packaged together with Malaysia Tourism Council (“MTC”) to get Malaysia tourism ready for post pandemic inbound travellers. Tracvirus has listed MOH approved quarantine hotels and centers as the one-stop solution provider to MTC members.

Tracvirus was developed by Nexgram sub-subsidiary Medic Data Science Pte Ltd (“MDS”), and distributed by another sub-subsidiaries of the Company, TRI-G, is an electronic health pass system for travellers aimed at facilitating entry into Malaysia amidst the ongoing Covid-19 pandemic.

The system, which is designed and operated by Nexgram for the use by government departments including MOH, is accessible at and has gone live since June this year.

It serves as an online portal for inbound travellers to register and pay for mandatory Covid- 19 swab tests prior to arrival, thus making the process of entering Malaysia more efficient and convenient. The system is integrated to foreign countries and act as reciprocal Covid-19 tests for outbound travellers. The system is integrating with International and local hotel and lodging groups to serve as quarantine centres for the ease of travellers, targeted to launch before end of the year.

Tracvirus Open Platform and E-Certificate are hosted on data security and user privacy protected International cloud system, and approved to use by International bodies including Google Play and Apple App Store. The SAAS API came with firewall and blockchain equivalent user access protection.

On July this year, Nexgram announced collaboration with the MTC to roll out Tracvirus e- certificate Covid-19 Test for 3.5 million tourism workers. The company had secured connectivity in foreign countries and shall be used in Indonesia, Hong Kong, Taiwan, Arab Saudi and most of European countries.

The company sub-subsidiary, TRI-G which is also a Medical Device Authority (“MDA”) licensed company which distribute Covid-19 Rapid Test Kit (“RTK”) and PCR systems for swab tests to hospitals and clinics in Malaysia.

About Nexgram Holdings Berhad

NEXGRAM HOLDINGS BERHAD is listed on the ACE Market of Bursa Malaysia Exchange and its headquarter is in Malaysia. The group is a diversified investment company having businesses in IT, security and surveillance, logistics, medical, property and other industries.

About Nexgram Biomedic Sdn Bhd

NEXGRAM BIOMEDIC GROUP is a global bio pharmaceutical company dedicate to develop new medical devices, drugs, and technologies in support of innovations in the medical field. The group subsidiaries include Medical Brands Inc and Tri-G Technologies Sdn Bhd (“TRI-G”) which distribute medical devices, VaccinesLab which conduct clinical trial and vaccine distribution, Medic Data Science (“MDS”) which develops Covid- 19 screening test and vaccine record tracking App using electronic certificates (E-Certs), Tracvirus for real-time record checking in work, school and travel, NMed Industries Sdn Bhd which trade, distribute and invest in medical device and personal protection equipment manufacturing, as well as Glove Alliance Sdn Bhd in medical and disposable nitrile gloves trading, contract manufacturing and distribution.

About Tracvirus E-Certificate (“E-Cert”)

Tracvirus E-Certificate or private labeled as “SafeTravelPass”, “My Travel Pass”, or “My Safe Travel” (collectively “E-Cert”), was launched and in use in Malaysia and Indonesia since July 2020, together with Malaysia Tourism Council (MTC), and accepted by government of Malaysia to be use by Ministry of Health (MOH) and other government agencies. The Tracvirus Open Platform is developed by Medic Data Science Ltd (“MDS”), and licensed to Tri-G Technologies Sdn Bhd (“TRI-G”) for the use in Malaysia. The platform’s “SafeTravelPass” system is developed for Ministry of Health and government agencies Covid-19 screening test and quarantine payment for all national borders, inbound and outbound travellers, either airport, seaport or borders. The Tracvirus application and e-certificates came with QR Code recognised worldwide. Tracvirus Open Platform came with secured user privacy and third party data access protection, hosted by International cloud servers and mirrors in Malaysia, Indonesia, China, and USA. Tracvirus Lab System is solely controlled by respective countries’ Health Ministry approved laboratories, where sample test and reports are using QR Code directly update by labs to relevant government system without third party access, while separately delivered to lab or clinics end users in real-time. The process flow is first in the world to use unified E-Certification and licensed by licensees worldwide since the start of the Covid-19 Pandemic.